- €5.07bn
- €7.83bn
- €9.54bn
Annual income statement for Arkema SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,884 | 9,519 | 11,550 | 9,514 | 9,544 |
Cost of Revenue | |||||
Gross Profit | 1,548 | 2,143 | 2,580 | 1,960 | 1,939 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7,284 | 7,786 | 10,263 | 8,833 | 8,958 |
Operating Profit | 600 | 1,733 | 1,287 | 681 | 586 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 513 | 1,676 | 1,220 | 602 | 507 |
Provision for Income Taxes | |||||
Net Income After Taxes | 335 | 1,307 | 966 | 425 | 357 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 332 | 1,309 | 965 | 418 | 354 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 304 | 1,293 | 949 | 402 | 338 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.74 | 11.2 | 14.1 | 5.97 | 5.73 |
Dividends per Share |